Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans
about
Gender analysis of moxifloxacin clinical trialsEfficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains.Tissue pharmacokinetics of levofloxacin in human soft tissue infections.Moxifloxacin in the treatment of skin and skin structure infections.Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)10 years' experience with the pneumococcal quinolone moxifloxacin.Application of microdialysis for pharmacokinetic-pharmacodynamic modelling.A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge.Intrabronchial Microdialysis: Effects of Probe Localization on Tissue Trauma and Drug Penetration into the Pulmonary Epithelial Lining Fluid.Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections.High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate
P2860
Q28538319-9ACD6104-D216-4293-8799-F983D4884D0FQ33812856-FB643617-ECE6-49FF-8298-25770D2A5929Q33836578-ACEEE21D-2659-470B-84C2-86458C0146ADQ34077095-F8641BCF-F136-4653-98EE-78CFB2736F51Q34510414-64AED9D1-6ABE-4CB5-872A-7A40A79A3C0AQ34737184-64FEBF54-272D-4B36-8500-4DF7334282D5Q35635671-67B9D6A6-9FD7-4D18-859E-B59B2A373CDCQ35826148-86407A1E-E70B-46EE-BE01-3491558926A6Q35919259-707C8CFA-82C3-460D-BA61-846AE2B4DF3DQ36341683-BCC63A99-F070-491B-BD08-110622F6220DQ37579919-2EA6CD48-3752-4904-8CE3-05C3006DBB39Q38089788-A69C1BCC-8B28-4482-A87D-C9870E2EC245Q38223948-98532DCE-CD99-4416-A26F-44D799D1C5F6Q40290562-3EF457EC-9193-41E4-A897-57B74A338B11Q40667360-12EF3075-DB09-45B7-84E0-128EFCB5F5E7Q41134829-09308D85-F26D-464F-834B-742D0D94155CQ41534755-37571A16-6F14-48E1-8B7A-FEF5B485E615Q43106836-2B8488C8-7D3E-4C20-92B6-A5A1618DAC3BQ45939590-E20AA518-4BF6-4C48-9114-77DA3E6906C5Q53853180-224058CD-E822-4666-8AB0-B0305214D368Q57543731-186D124F-5C99-4341-9DAB-5438D93D8646
P2860
Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@ast
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@en
type
label
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@ast
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@en
prefLabel
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@ast
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@en
P2093
P2860
P1476
Penetration of moxifloxacin in ...... eous adipose tissues in humans
@en
P2093
Christian Joukhadar
Edith Lackner
Erich Minar
Florian Kovar
Heino Stass
Markus Müller
Ulrike Müller-Zellenberg
P2860
P304
P356
10.1128/AAC.47.10.3099-3103.2003
P407
P577
2003-10-01T00:00:00Z